Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 25.60
-0.60 (-2.29%)
At close: Mar 2, 2026
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 1.09 billion as of March 2, 2026. Its market cap has decreased by -5.31% in one year.
Market Cap
1.09B
Enterprise Value
1.09B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
25.60
Market Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 1.09B, an increase of 191.09%. That is a compound annual growth rate of 13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.09B | -16.69% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.57B |
| Diamyd Medical AB | 2.04B |
| Egetis Therapeutics AB | 1.81B |
| BioInvent International AB | 1.53B |
| Cantargia AB | 1.18B |
| Genovis AB (publ.) | 1.14B |
| SynAct Pharma AB | 1.05B |
| Medivir AB | 864.03M |